PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Regulatory News:
STENTYS (FR0010949404 — STNT), a medical technology company commercializing the world's first and only Self-Apposing® coronary stent, today announces its annual results for the year to December 31, 2015, as approved by the Board of Directors on March 15, 2016.
STENTYS (FR0010949404 — STNT), a medical technology company commercializing the world's first and only Self-Apposing® coronary stent, today announces its annual results for the year to December 31, 2015, as approved by the Board of Directors on March 15, 2016.
